A river running fast between stands of fir in the Cascades, under flat evening light

Western United States · Private investment

Patient capital, creatively invested for the long haul.

We acquire controlling equity in stable, mature, technically complex businesses, without intent to sell.

About us


A long-term, stewardship approach to investing.

Watershed Holding Company acquires controlling equity in stable, mature, technically complex businesses across the Western United States. Built on a foundation of science and engineering, these businesses — test and measurement instrumentation, precision components, advanced materials — solve problems that others can’t.

  • We have a long time horizon.

    The things that make a business valuable — capable people, healthy systems, a trustworthy reputation — take years to build and require constant reinvestment. Because we aim to own indefinitely, our focus is on building those elements, not depleting them for short-term gain.

  • We support independence.

    We aren’t a giant competitor looking to fold your business into an organization with competing values. The company keeps its name, its customers, its people, and its essence. It has been successful for a reason.

Core values

  • Integrity

    We do what we say we’ll do, every time. No surprises.

  • Curiosity

    We ask questions, listen deeply, and seek first to understand.

  • Kindness

    We treat people with respect and lead with empathy.

  • Determination

    We never give up.

David Working

David Working

Managing Partner

David founded Watershed to build on his experiences advising middle-market investors across the Pacific Northwest and Alaska on investment strategy, execution, and management. He has seen firsthand how thoughtful ownership can guide and support a business in transition, and how conflict can destroy it.

David lives just outside of Boise, Idaho with his wife and two boys. Before a career in investing, he began his career at a laboratory benchtop, pursuing tissue engineering research using novel biomaterials. David holds a B.S. in Biomedical Engineering from Washington University in St. Louis and an MBA from Duke University.

Approach


First, do no harm.

We are business builders. The companies we look for already make something that works — proven products, engineering that took years to get right, and customers who would notice immediately if either slipped. The first obligation is to not break any of that.

After that, we focus on systems and foundations, slowly but surely. Since we are not preparing a business for somebody else’s diligence in three years, the work tends to be unglamorous, cumulative, and effective.

In roughly this order:

  1. Information systems

    Financial and operational data are knowledge. Clear, accessible information provides a foundation of truth for every part of the business.

  2. Mission alignment

    A goal is only useful if the floor and the front office describe it the same way. We spend real time establishing where the business is going, then making sure day-to-day execution actually points that direction.

  3. Human capital development

    Complexity almost always arrives before the org chart is ready for it. We would rather hire ahead of the curve and develop the people already in the building than wait for something to break and then call the repair a reorganization.

Investment criteria


What we look for.

These are proxies for our interest, but not strict boundaries. If a business is close but not exact, it is still worth a conversation.

Geography

Western United States. Bonus points for Washington, Oregon, or Idaho.

Size

$3–15M EBITDA on $20–100M of revenue.

Stage

Stable, mature operating businesses. Not early-stage, and not turnarounds.

Structure

Controlling equity. We are glad for an owner or management team to keep a meaningful stake and stay involved.

Industries

Technically complex manufacturing: test and measurement instrumentation, precision components, advanced materials. Applications across industries: aerospace, automotive, defense, energy, life sciences, and everything in between. The list describes where we have built literacy, not a fence. Adjacent to it, ask us.

Time horizon

No predetermined exit timeline. We buy to hold.

Where we’re a poor fit

Companies followed by a long string of litigation; companies whose value depends on a deep, immediate cultural turnaround; any situation where the plan requires stripping the operation to make the numbers work. We would rather say so in the first conversation than spend a few months getting to the same answer.

Content


Field Notes.

Short briefs on what we are seeing in the subsectors we follow: lead times, labor, tooling, capital equipment, the parts of an industry that never reach the trade press. Written with intent to share our learnings, for readers already embedded. Every figure is footnoted.

  • Precision components July 2026

    Everyone is buying machines. Nobody is hiring.

    Machine tool orders are running nearly 30% ahead of last year while manufacturing employment contracts and backlogs sit flat. Two readings fit the same data, and the difference matters.

    Read the brief →
  • Test and measurement instrumentation April 2026

    Nothing Can Be Easy

    Structural demand is genuinely strong. The day-to-day operating reality — specialty inputs that can't be substituted, tariff exposure, and compliance documentation as a growth cost center — is more complicated.

    Read the brief →

Contact us


Let’s compare notes.

We are always learning a new corner of this market and happy to trade observations with anyone else engaged — owners, operators, and advisors alike. No agenda beyond that.

Anything you send stays between us. We will not pass your name to anyone.